The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Chlamydia pneumoniae (TWAR)
Open accessAbstract
Chlamydia pneumoniae (TWAR) is a recently recognized third species of the genus Chlamydia that causes acute respiratory disease. It is distinct from the other two chlamydial species that infect humans, C. trachomatis and C. psittaci, in elementary body morphology and shares less than 10% of the DNA homology with those species. The organism has a global distribution, with infection most common among children between the ages of 5 and 14 years. In children, TWAR infection is usually mild or asymptomatic, but it may be more severe in adults. Pneumonia and bronchitis are the most common clinical manifestations of infection, and TWAR is responsible for approximately 10% of cases of pneumonia and 5% of cases of bronchitis in the United States. The microimmunofluorescence serologic assay is specific for TWAR and can distinguish between recent and past infections. The organism can be isolated in cell culture; however, PCR techniques have recently facilitated its detection in tissues and clinical specimens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Saikku, P., Mattila, K., Nieminen, M. S., Huttunen, J. K., Leinonen, M., Ekman, M.-R., Mäkelä, P. H., & Valtonen, V (1988) · The Lancet · doi:10.1016/s0140-6736(88)90741-6 · Cited by 1,964
Saikku, P., Leinonen, M., Tenkanen, L., Linnanmäki, E., Ekman, M.-R., Manninen, V., Mänttäri, M., Frick, M. H., & Huttunen, J. K. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-4-273 · Cited by 786
Demonstration of Chlamydia pneumoniae in Atherosclerotic Lesions of Coronary Arteries
Kuo, C.-C., Shor, A., Campbell, L. A., Fukushi, H., Patton, D. L., & Grayston, J. T. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.4.841 · Cited by 762
Self-citationA New Chlamydia psittaci Strain, TWAR, Isolated in Acute Respiratory Tract Infections
Grayston, J. T., Kuo, C.-C., Wang, S.-P., & Altman, J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607173150305 · Cited by 718
Self-citationHahn, D. L. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470020051031 · Cited by 574
Wang, S.-P., & Grayston, J. T. (1970) · American Journal of Ophthalmology · doi:10.1016/0002-9394(70)90096-6 · Cited by 536
Self-citationDetection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques.
Shor, A., Kuo, C. C., & Patton, D. L. (1992) · PubMed · Cited by 455
Self-citationThom, D. H. (1992) · JAMA · doi:10.1001/jama.268.1.68 · Cited by 397
Chlamydia pneumoniae sp. nov. for Chlamydia sp. Strain TWAR
GRAYSTON, J. T., KUO, C.-C., CAMPBELL, L. A., & WANG, S.-P. (1989) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-39-1-88 · Cited by 379
Self-citationChlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old).
Kuo, C. C., Grayston, J. T., Campbell, L. A., Goo, Y. A., Wissler, R. W., & Benditt, E. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6911 · Cited by 373
Self-citation
Cited by
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Musher, D. M., & Fine, M. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313954 · Cited by 2,286
Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., et al. (2006) · Stroke · doi:10.1161/01.str.0000223048.70103.f1 · Cited by 1,368
Everett, K. D. E., Bush, R. M., & Andersen, A. A. (1999) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/00207713-49-2-415 · Cited by 1,075
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., et al. (2001) · Stroke · doi:10.1161/01.str.32.1.280 · Cited by 905
Comparative genomes of Chlamydia pneumoniae and C. trachomatis
Kalman, S., Mitchell, W., Marathe, R., Lammel, C., Fan, J., Hyman, R. W., Olinger, L., Grimwood, J., Davis, R. W., & Stephens, R. (1999) · Nature Genetics · doi:10.1038/7716 · Cited by 681
The chlamydial developmental cycle: Figure 1
AbdelRahman, Y. M., & Belland, R. J. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2005.03.002 · Cited by 631
Chlamydial Persistence: beyond the Biphasic Paradigm
Hogan, R. J., Mathews, S. A., Mukhopadhyay, S., Summersgill, J. T., & Timms, P. (2004) · Infection and Immunity · doi:10.1128/iai.72.4.1843-1855.2004 · Cited by 461
Maass, M., Bartels, C., Engel, P. M., Mamat, U., & Sievers, H.-H. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00016-3 · Cited by 367
File, T. M., Segreti, J., Dunbar, L., Player, R., Kohler, R., Williams, R. R., Kojak, C., & Rubin, A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.1965 · Cited by 360
Read, T. D. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg321 · Cited by 311
Inactivation of Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae by ozone
Yamazaki, T., Inoue, M., Ogawa, M., Shiga, S., Kishimoto, T., Hagiwara, T., Matsumoto, T., & Hayashi, T. (2004) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2004.01506.x · Cited by 286
Chlamydia pneumoniae — an infectious risk factor for atherosclerosis?
Campbell, L. A., & Kuo, C.-C. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro796 · Cited by 277
Self-citationPrincipi, N., Esposito, S., Blasi, F., Allegra, L., & the Mowgli Study Group (2001) · Clinical Infectious Diseases · doi:10.1086/319981 · Cited by 266
Evidence of Systemic Dissemination of Chlamydia pneumoniae via Macrophages in the Mouse
Moazed, T. C., Kuo, C., Grayston, J. T., & Campbell, L. A. (1998) · The Journal of Infectious Diseases · doi:10.1086/515280 · Cited by 264
Self-citationCurrent and emergent strategies for disinfection of hospital environments
Abreu, A. C., Tavares, R. R., Borges, A., Mergulhao, F., & Simoes, M. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt281 · Cited by 235
Bacterial Infection and Alzheimer's Disease: A Meta-Analysis
Maheshwari, P., & Eslick, G. D. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140621 · Cited by 183
Chlamydia pneumoniae Infection in Human Monocytes
Airenne, S., Surcel, H.-M., Alakärppä, H., Laitinen, K., Paavonen, J., Saikku, P., & Laurila, A. (1999) · Infection and Immunity · doi:10.1128/iai.67.3.1445-1449.1999 · Cited by 138
“Chlamydia pneumoniae is an obligate intracellular bacterium involved in a wide spectrum of respiratory tract infections (9, 13).”
BackgroundHacking the host: exploitation of macrophage polarization by intracellular bacterial pathogens
Thiriot, J. D., Martinez-Martinez, Y. B., Endsley, J. J., & Torres, A. G. (2020) · Pathogens and Disease · doi:10.1093/femspd/ftaa009 · Cited by 103
Exposure to Chlamydia pneumoniae infection and progression of age-related macular degeneration
Robman, L., Mahdi, O., McCarty, C., Dimitrov, P., Tikellis, G., McNeil, J., Byrne, G., Taylor, H., & Guymer, R. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi130 · Cited by 77
Boelen, E., Stassen, F. R. M., van der Ven, A. J. A. M., Lemmens, M. A. M., Steinbusch, H. P. J., Bruggeman, C. A., Schmitz, C., & Steinbusch, H. W. M. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0252-3 · Cited by 41
“Cpn is a widespread, obligatory intracellular pathogen, often causing acute respiratory infections including pneumonia, sinusitis and bronchitis [10, 11, 15].”
BackgroundMyD88-dependent changes in the pulmonary transcriptome after infection with Chlamydia pneumoniae
Rodríguez, N., Mages, J., Dietrich, H., Wantia, N., Wagner, H., Lang, R., & Miethke, T. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00011.2007 · Cited by 37
Edvinsson, M., Frisk, P., Molin, Y., Hjelm, E., & Ilbäck, N.-G. (2008) · BioMetals · doi:10.1007/s10534-007-9114-7 · Cited by 22
“pneumoniae is a respiratory pathogen that is estimated to cause about 10% of all community-acquired pneumonia (Kuo et al. 1995).”
Background(1999) · PubMed · Cited by 17
Amphiphysin IIm Is Required for Survival of Chlamydia pneumoniae in Macrophages
Gold, E. S., Simmons, R. M., Petersen, T. W., Campbell, L. A., Kuo, C.-C., & Aderem, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040546 · Cited by 12
Self-citation
Metadata
- Authors
- Kuo, C. C., Jackson, L. A., Campbell, L. A., & Grayston, J. T.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1995-10
- Volume
- 8
- Issue
- 4
- Pages
- 451-461
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2160722686
- Cited by
- 819
- References
- 59
- FWCI
- 19.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.